Steven R. Pacelli - 24 Jan 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Reporting relationship: Managing Dir., Dexcom Ventures
Issuer ticker: DXCM
Reported as of: 24 Jan 2022
Net transaction value: -$104,192
SEC form: 4
Accepted by SEC: 26 Jan 2022, 15:27:17 UTC
Prior SEC filing: 23 Dec 2021
Next SEC filing: 24 Feb 2022
Source filing: View source filing
Reporting owner signature: By: Jereme Sylvain For: Steven R Pacelli

Key filing fact

Steven R. Pacelli filed Form 4 for DEXCOM INC (DXCM) on 26 Jan 2022.

Key facts

This page summarizes Steven R. Pacelli's Form 4 filing for DEXCOM INC (DXCM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Jan 2022, 15:27.

Change

Previous filing in this sequence was filed on 23 Dec 2021.
Current net transaction value: -$104,192.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXCM transaction

Common Stock

Sale

Transaction value: $104,192
Shares: -250
Change %: -0.72%
Price: $416.77
Shares after: 34,620
Date: 24 Jan 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

Footnote F2

Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.